<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02221934</url>
  </required_header>
  <id_info>
    <org_study_id>003-0001</org_study_id>
    <secondary_id>QUEST Trial</secondary_id>
    <nct_id>NCT02221934</nct_id>
  </id_info>
  <brief_title>Electrical Nerve Block for Amputation Pain</brief_title>
  <official_title>High-Frequency Nerve Block for Post-Amputation Pain: A Pivotal Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Neuros Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Neuros Medical, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the clinical trial is to learn whether electrical nerve block via the Altius&#xD;
      System is a safe and effective treatment for patients with post-amputation pain.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Altius System is an implanted device designed to electrically block nerve signals and&#xD;
      alleviate pain. Use of this device may be associated with providing an effective,&#xD;
      mechanism-based yet non-destructive, treatment for managing intractable limb pain in&#xD;
      amputees. In a given patient, the Altius System will be deemed effective if treatment results&#xD;
      in 50% reduction of pain score for more than 50% of all pain episodes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 9, 2014</start_date>
  <completion_date type="Anticipated">January 31, 2027</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Effectiveness Endpoint: Reduction of Pain Level by 50% from Baseline</measure>
    <time_frame>3 months post implant</time_frame>
    <description>Demonstration of 50% reduction in a Numerical Rating Scale (NRS) pain score from pre-treatment to post-treatment for more than 50% of all pain episodes. Study success will be determined by a superiority test on the difference between responder rates in the Test group (those receiving the treatment) and Control group (those who do not receive treatment).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary Safety Endpoint: Incidence of Reported and Adjudicated Serious Adverse Events</measure>
    <time_frame>From consent through 3 months post implant</time_frame>
    <description>Incidence of all serious adverse events including serious adverse device events and unanticipated adverse device events.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary Effectiveness: Pain Relief after 2 hours</measure>
    <time_frame>12 months post implant</time_frame>
    <description>Average percent change of pain intensity from before treatment, 30 minutes post treatment, and 2 hours post treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Effectiveness: Pain Days per Week</measure>
    <time_frame>12 months post implant</time_frame>
    <description>Average number of pain days compared at Month 3, Month 6 and Month 12 to Baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Effectiveness: Pain Medication Use</measure>
    <time_frame>12 months post implant</time_frame>
    <description>Average morphine equivalent dose per day over two weeks compared at Month 3, Month 6 and Month 12 to Baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Effectiveness: Pain Interference to Activities of Daily Living (ADL</measure>
    <time_frame>12 months post implant</time_frame>
    <description>Brief Pain Inventory summary score compared at Month 3, Month 6 and Month 12 to Baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Effectiveness: Health-related quality of life (HR-QOL)</measure>
    <time_frame>12 months post implant</time_frame>
    <description>EQ-5D summary index, SF-12 physical component and mental component summary compared at Month 3, Month 6 and Month 12 to Baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Effectiveness: Patient Global Impression of Change (PGIC)</measure>
    <time_frame>12 months post implant</time_frame>
    <description>Comparison of Patient Global Impression of Change across the Month 3, Month 6 and Month 12 office visits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Safety</measure>
    <time_frame>12 months post implant</time_frame>
    <description>Incidence of all Non-Serious Adverse Events, including Non-Serious Adverse Events, Non-Serious Adverse Device Events, and Unanticipated (Non-Serious) Adverse Device Events from the time of consent through 12 months post implant.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Exploratory Efficacy: Prosthetic Use</measure>
    <time_frame>12 months post implant</time_frame>
    <description>Average hours of prosthetic use per week averaged across two weeks compared at Month 3, Month 6 and Month 12 to Baseline.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">180</enrollment>
  <condition>Post-Amputation Pain</condition>
  <condition>Phantom Limb Pain</condition>
  <condition>Residual Limb Pain</condition>
  <condition>Stump Pain</condition>
  <arm_group>
    <arm_group_label>Signal more likely to block nerve</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Electrical signal delivered to nerve by Altius, a device designed for high-frequency nerve block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Signal less likely to block nerve</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Electrical signal delivered to nerve by Altius, a device designed for high-frequency nerve block</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Altius</intervention_name>
    <description>Electrical signal</description>
    <arm_group_label>Signal less likely to block nerve</arm_group_label>
    <arm_group_label>Signal more likely to block nerve</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 21 years old&#xD;
&#xD;
          -  Unilateral amputated leg ≥ 12 months&#xD;
&#xD;
          -  Chronic post amputation pain ≥ 6 months&#xD;
&#xD;
          -  Pain episodes typically lasting ≥ 60 minutes&#xD;
&#xD;
          -  Stable drug regimen ≥ 4 weeks&#xD;
&#xD;
          -  No changes to medications or prosthesis for 3-month primary study period&#xD;
&#xD;
        Key Exclusion Criteria:&#xD;
&#xD;
          -  Implanted with an active implantable medical device (i.e. pacemaker)&#xD;
&#xD;
          -  Confounding source of pain that interferes with reporting of limb pain&#xD;
&#xD;
          -  Uncontrolled diabetes&#xD;
&#xD;
          -  Spasticity preventing full range of motion of involved side&#xD;
&#xD;
          -  Extremely short stump; sits on end&#xD;
&#xD;
          -  Untreated psychological condition (i.e. borderline personality)&#xD;
&#xD;
          -  Condition requiring MRI studies or diathermy after device implant&#xD;
&#xD;
          -  Life expectancy of less than 24 months&#xD;
&#xD;
          -  Progressive neurological disease (i.e. multiple sclerosis)&#xD;
&#xD;
          -  Subjects with active local or systemic infection or immunocompromised&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leonardo Kapural, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center for Clinical Research, Winston-Salem NC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Arizona Pain Institute</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85258</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences (UAMS)</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nona Medical Arts</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32827</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University / Grady Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Legacy Brain &amp; Spine LLC</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30339</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Drug Studies America</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30060</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Illinois Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ochsner Clinic Foundation</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Clinical Research</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Pain Management</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Meta Medical Research Institute</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45432</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kettering Medical Center</name>
      <address>
        <city>Springboro</city>
        <state>Ohio</state>
        <zip>45066</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Surgical and Research Solutions</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Surgery Clinic</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Surgical Clinic</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor Scott and White Research Institute</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor Scott and White - Temple Memorial Vascular Surgery</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <zip>76508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Washington Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/25655583</url>
    <description>Neuros HFNB Pilot Study - Abstract</description>
  </link>
  <reference>
    <citation>Soin A, Shah NS, Fang ZP. High-frequency electrical nerve block for postamputation pain: a pilot study. Neuromodulation. 2015 Apr;18(3):197-205; discussion 205-6. doi: 10.1111/ner.12266. Epub 2015 Feb 5.</citation>
    <PMID>25655583</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 15, 2014</study_first_submitted>
  <study_first_submitted_qc>August 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 21, 2014</study_first_posted>
  <last_update_submitted>September 13, 2021</last_update_submitted>
  <last_update_submitted_qc>September 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>Chronic</keyword>
  <keyword>Amputation</keyword>
  <keyword>Phantom Pain</keyword>
  <keyword>Stump Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phantom Limb</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

